Cristina Bugés

📣 ESMO #ClinicalPracticeGuideline eUpdate on #OesophagealCancer: in resectable, locally advanced oesophageal adenocarcinoma or OGJ pre- & post-operative #chemotherapy is associated with improved survival vs #Neoadjuvant #Chemoradiotherapy. 🔗 ow.ly/R37w50UYlE9

ESMO Clinical Practice Guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric junction adenocarcinoma and metastatic squamous-cell carcinoma esmoopen.com/article/S2059-…

We are pleased to share part of our work @LegacyH2020 which reveals significant biological differences in gastric cancer between Europe and LATAM, centered on molecular type distribution, biomarker expression, cell cycle, and phenotypic attributes. doi.org/10.1007/s10120…

📢VIII Curs Immunoteràpia B-ARGO🩺🔬 🗓️6-7 Novembre 2024 🏥 Sala Polivalent IGTP Mar ✍️Link inscripció (gratuïta): forms.office.com/e/kTDsirs4zx

📢New edition: VII Curs Immunoteràpia B·ARGO 📍 Sala de Graus, edifici UAB-Can Ruti 🗓️ 4 i 5 Octubre 2023: 15h-18.30h 👉 Registration: us02web.zoom.us/webinar/regist… Us hi esperem‼️🧬🩺🔬 @ICO_oncologia @GTRecerca @hgermanstrias

La @_SEOM entrega sis beques a professionals de l’@ICO_oncologia per tal d’impulsar la #formació i la #recerca en #càncer. Aquesta setmana s'ha celebrat el congrés de la #SEOM amb una àmplia representació de professionals de la institució. Enhorabona als guardonats!

@incliva_iis @manu_cs13 @ValeGambardella @fundacionmutua We are very Excited for starting this project in collaboration with @FoxChaseCancer @Isra_canadas @ICO_oncologia @chierrocarbo @BugesCris 😃.Thanks to @fundacionmutua for supporting this project 🙏🏻